logo
go
 
 
 
   
Jonathan J. Fleming - Managing General Partner
Boston, MA

Jonathan Fleming is the Managing General Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science technology based investments, with offices in Boston and Connecticut.
- more

   
Matthew A. Gibbs - General Partner
Boston, MA

Matthew Gibbs is a General Partner of Oxford Bioscience Partners and Oxford Energy Partners, the energy focused affiliate fund of Oxford, a Billion dollar venture capital firm. Mr. Gibbs joined Oxford in 1997 and became a General Partner in 2005. Mr. Gibbs has over 17 years of venture capital experience.
- more

   
Ellen S. Baron, Ph.D. - Partner
Boston, MA

Dr. Baron joined Oxford Bioscience Partners in 2003 and is currently a Partner at the firm. She has over 20 years of operating and investment expertise in the pharmaceutical and biotechnology industry and is focused on all areas of healthcare investing, principally in biotherapeutics.
- more

   
B. Christopher Kim, Ph.D. - Partner
Boston, MA

Dr. Kim has extensive experience in life sciences operations as well as scientific research. He is Founding Partner of the Korea-Seoul Life Science Fund (KSLSF) which was launched in early 2011.
- more

   
Edmund M. Olivier - Senior General Partner
Malibu, CA

Mr. Olivier has a profitable record of financing and managing biotechnology and healthcare investments over the last 20 years.
- more

   
Cornelius T. Ryan - Founding General Partner
Westport, CT

Cornelius T. Ryan (Neil) co-founded Oxford Partners in 1981 and is the only partner involved in all previous Oxford funds. Neil is a Special Limited Founding Partner of Oxford Bioscience III and a General Partner of Oxford Bioscience I and II. - more

   
Alan G. Walton, Ph.D., D.Sc. - Senior General Partner
Westport, CT

Alan G. Walton, Ph.D., D.Sc. has served as a director of our company since March 2003. Dr. Walton joined Oxford Partners as a General Partner in 1987.
- more

 



 
 
 
   
Daniel Cole - Venture Partner
Boston, MA

Dan Cole joined Oxford Bioscience Partners as a Venture Partner during 2009. He also serves as a General Partner of Spray Venture Partners, which he joined in 1996.
- more

   
Douglas M. Fambrough, Ph.D. - Venture Partner
Boston, MA

Dr. Fambrough is a Venture Partner with OBP and serves as CEO of OBP portfolio company Dicerna Pharmaceuticals, a second generation "RNA Interference" company which he co-founded.
- more

 



 
 
   
Michael J. Magliochetti, Ph.D. - Entrepreneur-in-Residence
Boston, MA

Michael J. Magliochetti, Ph.D. brings significant business operations, technical and strategic management experience to his role as Entrepreneur-in-Residence at Oxford Bioscience Partners. - more

 



 
 
   
Manuel A. Navia, Ph.D. - Executive-in-Residence
Boston, MA

Dr. Navia is currently an Executive-in-Residence at Oxford Bioscience Partners. He is also a consultant for a number of pharmaceutical companies in the Boston area.
- more

   
David Poorvin, Ph.D. - Executive-in-Residence
Boston, MA

Dr. Poorvin has over 35 years of experience in the pharmaceutical and biotech industry.
- more

   
Alan Watson, Ph.D., M.B.A. - Executive-in-Residence
Boston, MA

Dr. Watson has almost thirty years of experience in the pharmaceutical and biotechnology industries. Dr. Watson is currently the Chief Executive Officer of Estabrook Pharmaceuticals, Inc.
- more

 



 
 
   
Raymond Charest - Chief Financial Officer
Boston, MA

Mr. Charest is Chief Financial Officer of OBP. Prior to joining OBP in 1998, Mr. Charest served as Controller for MPM Capital L.P., a Cambridge, MA based firm. - more

   
Alexia Pearsall - Vice President of Finance
Boston, MA

Ms. Pearsall joined Oxford in 1999 as Controller and was promoted to Vice President of Finance in 2004.
- more